Hongsheng Li

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Brain Metastases

Prostate Cancer

Top Venues

Molecular pharmaceutics

Contrast media & molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Ruoxue Dai, Zhikai Cai, Rui Hu, Yueqi Huang, Lilan Fu, Jiaqi Yang, Kongzhen Hu, Hongsheng Li
177 Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer. Molecular pharmaceutics 21 (2) (2023)
Ruoxue Dai, Zhikai Cai, Rui Hu, Yueqi Huang, Lilan Fu, Jiaqi Yang, Kongzhen Hu, Hongsheng Li
177 Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer. Molecular pharmaceutics 21 (2) (2023)
Ruoxue Dai, Zhikai Cai, Rui Hu, Yueqi Huang, Lilan Fu, Jiaqi Yang, Kongzhen Hu, Hongsheng Li
177 Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer. Molecular pharmaceutics (2023)
Lijuan Wang, Ganghua Tang, Kongzhen Hu, Xinran Liu, Wenlan Zhou, Hongsheng Li, Shun Huang, Yanjiang Han, Li Chen, Jinmei Zhong, Hubing Wu
Comparison of 68 Ga-FAPI and 18 F-FDG PET/CT in the Evaluation of Advanced Lung Cancer. Radiology 303 (1) (2022)
Yin Zhang, Lijuan Wang, Sirui Yu, Kongzhen Hu, Shun Huang, Youcai Li, Hubing Wu, Hongsheng Li, Quan-Shi Wang
Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide 18F-iCREKA: Comparison with Its Contrasted Linear Peptide. Contrast media & molecular imaging 2019 (2019)